News
Karo Intressenter AB increases the offer price in its public cash offer to the shareholders in Karo Pharma Aktiebolag and extends the acceptance period
The link was copied!
For more information, click here.
Exclusive News and Insights Every Week
Add your email address below to sign up for our EQT newsletters.